Back to Search
VINNY RAM, MD
MD
Interventional Cardiology Physician
NPI: 1881895159IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
43035(AZ)
Cardiovascular Disease Physician
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
43035(AZ)
Interventional Cardiology PhysicianPrimary
Internal Medicine — Interventional Cardiology
Code: 207RI0011X
43035(AZ)
Education
STATE UNIVERSITY OF NEW YORK DOWNSTATE MEDICAL CENTER
Class of 2006
Research & Publications (20)
Ab initio and experimental studies on structure and vibrational spectra of some partially reduced benzo[c]phenanthrenes.
PMID 18930437·Spectrochim Acta A Mol Biomol Spectrosc·2009
8-other
Telmisartan, ramipril, or both in patients at high risk of vascular events.
PMID 18655247·N Engl J Med·2008
8-other
An efficient de novo synthesis of partially reduced phenanthrenes through C-C insertion.
PMID 17705542·J Org Chem·2007
8-other
Structural and spectroscopic studies on some chloropyrimidine derivatives by experimental and quantum chemical methods.
PMID 16098792·Spectrochim Acta A Mol Biomol Spectrosc·2006
8-other
6-Aryl-4-methylsulfanyl-2H-pyran-2-one-3-carbonitriles as PPAR-gamma activators.
PMID 15953723·Bioorg Med Chem Lett·2005
8-other
Synthesis and in vivo antihyperglycemic activity of 5-(1H-pyrazol-3-yl)methyl-1H-tetrazoles.
PMID 15808480·Bioorg Med Chem Lett·2005
7-preclinical
Biaryls and heterobiaryls as alpha-glucosidase and protein tyrosine phosphatase inhibitors.
PMID 15713383·Bioorg Med Chem Lett·2005
8-other
Synthesis of bicyclic biaryls as glucose-6-phosphatase inhibitors.
PMID 15018928·Bioorg Med Chem·2004
7-preclinical
Advances in molecular targets and chemotherapy of tuberculosis.
PMID 15349129·Drugs Today (Barc)·2004
6-review
Synthesis and glucose-6-phosphatase inhibitory activity of (thiouriedo)alkanoic acid esters.
PMID 15109654·Bioorg Med Chem Lett·2004
7-preclinical
Antihyperglycemic activity of 2-methyl-3,4,5-triaryl-1H-pyrroles in SLM and STZ models.
PMID 14980641·Bioorg Med Chem Lett·2004
4-observational
Hepatoprotection by 3-bromo-6-(4-chlorophenyl)-4-methylthio-2H-pyran-2-one against experimentally induced liver injury in rats.
PMID 14764243·Acta Pharm·2003
7-preclinical
Therapeutic significance of peroxisome proliferator-activated receptor modulators in diabetes.
PMID 14566384·Drugs Today (Barc)·2003
6-review
Therapeutic role of peroxisome proliferator-activated receptors in obesity, diabetes and inflammation.
PMID 12790340·Prog Drug Res·2003
6-review
Synthesis and antihyperglycemic activity of suitably functionalized 3H-quinazolin-4-ones.
PMID 12735990·Bioorg Med Chem·2003
7-preclinical
Synthesis of aminonicotinonitriles and diaminopyridines through base-catalyzed ring transformation of 2H-pyran-2-ones.
PMID 12662083·J Org Chem·2003
8-other
Visceral Leishmaniasis: Clinical Features, Pathology, Diagnosis and Chemotherapeutic Developments.
PMID 12677177·Drug News Perspect·2002
8-other
A convenient synthesis and hepatoprotective activity of imidazo[1,2-c]pyrimido[5,4-e]pyrimidine, tetraazaacenaphthene and tetraazaphenalene from cyclic ketene aminals through tandem addition-cyclization reactions.
PMID 11886790·Bioorg Med Chem·2002
7-preclinical
A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes.
PMID 11824861·Am J Hypertens·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 13460 N 94TH DR STE J1
PEORIA, AZ 85381 - Phone
- (623) 876-8816
Quick Facts
- NPI
- 1881895159
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 20
- Publications
- 20
Are you this provider?
Claim Your Profile